BG
Last reporting period 30 Sep, 2023
Updated 18 Sep, 2024
Last price
—
Market cap $B
0.008
Exchange
XNAS - Nasdaq
-0.001 B
Last period FCFE ,USD
What is FCFE ?
Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.
See also BioNexus Gene
Company Analysis
BGLC valuation, rating, competitors, insights and company profile
Eyestock Rating
BGLC financial analysis by Eyestock methodology
Valuation
BGLC valuation using historical relative method
Statements
BGLC Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BGLC dividend yield and annual dividend
Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.
BioNexus Gene`s FCFE for the period ended 2023-09-30 is -0.001 B USD
